Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Endocrinology · Familial Non-Autoimmune Hyperthyroidism

Understanding Your FNAH Diagnosis

At a Glance

FNAH is a rare genetic form of overactive thyroid caused by a TSHR gene change that can keep the thyroid switched on. Negative Graves’ antibodies, absent eye symptoms, persistent disease, and family patterns can help point to the diagnosis.

Receiving a diagnosis of Familial Non-Autoimmune Hyperthyroidism (FNAH) often marks the end of a long and confusing journey. For many, it follows years of being told they have Graves’ disease (the most common cause of an overactive thyroid), only for the standard treatments to fail or for blood tests to repeatedly come back without the expected antibodies [1][2].

Scope of this guide: This guide covers the diagnosis and management of FNAH, a rare genetic cause of non-autoimmune hyperthyroidism. Management differs by age and specific genotype. This guide does not replace the advice of your endocrinologist or genetic counselor.

If you feel a sense of relief—or even frustration—at finally having a genetic answer, you are not alone. This is an exceptionally rare condition. As of recent medical reviews, only a small number of families have been documented in the global medical literature [3][4]. Because it is so rare, many experienced endocrinologists may never have encountered a case in their entire careers.

The “Always-On” Switch

To understand FNAH, it helps to think of your thyroid like a lamp. In a healthy person, the brain sends a signal called TSH (Thyroid-Stimulating Hormone) to “plug in” the lamp and turn on the light. In Graves’ disease, the body’s immune system mistakenly creates antibodies that act like a faulty finger constantly pressing the “on” button.

In FNAH, the problem is different. You have a genetic variation in your TSHR (TSH receptor) gene [1]. This gene provides the instructions for the “socket” on your thyroid cells where the TSH signal is supposed to land. Because of this genetic change, the socket is often stuck in the “on” position, even when there is no signal from the brain and no antibodies present [5][2]. Your thyroid is essentially “leaking” or overproducing hormones because its internal machinery has difficulty turning itself off.

Clues That Point Away From Graves’ Disease

FNAH is often hidden in plain sight because its symptoms—racing heart, anxiety, weight loss, and heat intolerance—look exactly like other forms of hyperthyroidism (an overactive thyroid). However, several key factors often serve as clues:

  • Negative Antibodies: Unlike Graves’ disease, FNAH is “non-autoimmune.” This means the common blood tests for TRAb or TSI (antibodies that stimulate the thyroid) will usually come back negative [1][6]. While a strong clue, negative antibodies do not rule out Graves’ completely.
  • No Eye Symptoms: Most patients with FNAH do not develop thyroid eye disease (bulging or inflamed eyes), which is a common sign doctors look for when diagnosing Graves’ [2].
  • The Relapse Cycle: While Graves’ disease can sometimes go into remission, FNAH is persistent. Patients often find that their hyperthyroidism returns when they try to lower or stop their antithyroid medication [1][7].
  • Family Patterns: Because it is an autosomal dominant condition, it often runs through generations. If one parent has the variant, each child has a 50% chance of inheriting it [8]. However, it can also appear de novo, meaning a person is the first in their family to have the mutation [9].

A Spectrum of Experience

Even within the same family, FNAH does not look the same for everyone. This is known as variable expressivity [10]. One family member might be diagnosed as a toddler due to rapid growth and a high heart rate, while another might not be diagnosed until they are older adults with only mild symptoms [1][11].

Identifying the genetic variant provides a clear roadmap. It explains why past treatments might not have worked as expected and allows your care team to manage the specific mechanism of your thyroid. Identifying this variant also allows for cascade testing, helping other family members get diagnosed earlier [8][4].

Common questions in this guide

What is familial non-autoimmune hyperthyroidism (FNAH)?
FNAH is a rare genetic cause of an overactive thyroid. A change in the TSHR gene can leave the thyroid’s TSH receptor acting as if it is continually receiving an “on” signal, so the thyroid makes too much hormone even when Graves’ disease antibodies are absent.
How can doctors tell FNAH apart from Graves’ disease?
FNAH often has negative TRAb and TSI antibody tests, no thyroid eye disease, and hyperthyroidism that returns when antithyroid medication is reduced or stopped. These clues support FNAH but do not completely rule out Graves’ disease; genetic testing and the full clinical picture help confirm the diagnosis.
Is FNAH inherited, and could my children have it?
FNAH commonly follows an autosomal dominant inheritance pattern, so each child of a parent with the relevant TSHR variant has a 50% chance of inheriting it. The condition can vary widely within one family, and it can also arise as a new mutation in someone with no family history. Genetic counseling can help relatives decide about testing.
What symptoms can FNAH cause?
Symptoms can include a racing heart, anxiety, weight loss, and feeling unusually hot. Children may be identified because of rapid growth and a high heart rate, while adults may have milder symptoms; thyroid eye disease is uncommon.
Why does my hyperthyroidism come back when I lower my medicine?
FNAH is caused by a persistent change in the TSH receptor, so the thyroid may continue overproducing hormones when antithyroid medication is reduced or stopped. This differs from Graves’ disease, which can sometimes enter remission. Do not change medication without discussing it with your endocrinologist.
How should FNAH be monitored over time?
Because FNAH is persistent and severity can vary with age and genetic variant, the frequency of thyroid blood tests should be individualized. Ask your endocrinologist how often to check thyroid levels and whether your treatment plan should change over time.

Get notified when new evidence is published on Familial hyperthyroidism due to mutations in TSH receptor.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (11)
  1. 1

    TSHR Gly413Ser in familial nonautoimmune hyperthyroidism: a case report.

    Kelp O, Førsvoll J, Bischof F, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2026; doi:10.1515/jpem-2025-0617.

    PMID: 42665942
  2. 2

    Novel presentation of the c.1856A > G (p.Asp619Gly) TSHR gene-activating variant: relapsing hyperthyroidism in three subsequent generations manifesting in early childhood and an in vitro functional study.

    Bezdicka M, Kleiblova P, Soucek J, et al.

    Hormones (Athens, Greece) 2021; (20(4)):803-812 doi:10.1007/s42000-021-00299-x.

    PMID: 34142359
  3. 3

    Familial Non-autoimmune Hyperthyroidism in Family Members Across Four Generations Due To a Novel Disease-causing Variant in The Thyrotropin Receptor Gene.

    Malej A, Avbelj Stefanija M, Bratanič N, Trebušak Podkrajšek K

    Balkan journal of medical genetics : BJMG 2020; (23(2)):87-92 doi:10.2478/bjmg-2020-0022.

    PMID: 33816077
  4. 4

    Report of a family with three generations of undiagnosed familial nonautoimmune hyperthyroidism.

    Stephenson A, Punjwani Z, Eszlinger M, et al.

    Endocrinology, diabetes & metabolism case reports 2021; (2021()).

    PMID: 34866058
  5. 5

    Familial Non-Autoimmune Hyperthyroidism Caused by an Extracellular Domain Variant (p.Leu267Phe) of the TSH Receptor.

    Shimura K, Ichihashi Y, Abe K, et al.

    Hormone research in paediatrics 2026; (99(5)):623-631 doi:10.1159/000544836.

    PMID: 39987906
  6. 6

    An A627V-activating mutation in the thyroid-stimulating hormone receptor gene in familial nonautoimmune hyperthyroidism.

    Shin JH, Seo GH, Oh SH, et al.

    Annals of pediatric endocrinology & metabolism 2020; (25(4)):282-286 doi:10.6065/apem.2040076.038.

    PMID: 33401884
  7. 7

    Non-Autoimmune Hyperthyroidism Associated With a Novel Germline Mutation (D633N) in the TSH Receptor.

    Mori S, Osaki Y, Fukazawa H, et al.

    Case reports in endocrinology 2026; (2026()):3274433 doi:10.1155/crie/3274433.

    PMID: 42367683
  8. 8

    Inheritable and sporadic non-autoimmune hyperthyroidism.

    Ferraz C, Paschke R

    Best practice & research. Clinical endocrinology & metabolism 2017; (31(2)):265-275 doi:10.1016/j.beem.2017.04.005.

    PMID: 28648513
  9. 9

    Novel germline mutation (Leu512Met) in the thyrotropin receptor gene (TSHR) leading to sporadic non-autoimmune hyperthyroidism.

    Roberts SA, Moon JE, Dauber A, Smith JR

    Journal of pediatric endocrinology & metabolism : JPEM 2017; (30(3)):343-347.

    PMID: 28195550
  10. 10

    Familial Nonautoimmune Hyperthyroidism Due to a TSH Receptor Gene Pathogenic Variant.

    Takahashi S, Nishihara E, Fukata S, et al.

    JCEM case reports 2024; (2(10)):luae167 doi:10.1210/jcemcr/luae167.

    PMID: 39301178
  11. 11

    Familial neonatal nonautoimmune hyperthyroidism due to a gain-of-function (D619G) thyrotropin-receptor mutation.

    Taha D, Adhikari A, Flore LA

    Journal of pediatric endocrinology & metabolism : JPEM 2021; (34(2)):267-271 doi:10.1515/jpem-2020-0291.

    PMID: 33180037

This page is for informational purposes only and does not constitute medical advice. It explains FNAH and TSHR-related findings; your endocrinologist and genetic counselor should interpret your results and guide treatment.